Shoulder Innovations, Inc. SI

Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the N-22 Humeral Head, a titanium implant option for patients with metal hypersensitivity. Alongside the clearance, the company also announced the product's full commercial launch.

Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it has entered into an exclusive collaboration with ALM Ortho, Inc. ("ALM Ortho"), a leader in additive manufacturing of titanium orthopedic implants, to introduce a bespoke implant for the treatment of severe shoulder deformity and other highly complex revision cases, circumstances f

Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that it has entered into a settlement agreement with Catalyst OrthoScience Inc. ("Catalyst") to resolve all outstanding patent litigation between the two companies. The terms of the settlement agreement are confidential.

Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will participate in a fireside chat at the Morgan Stanley 24th Annual Healthcare Conference. The fireside chat will take place at 3:20 p.m. ET / 12:20 p.m. PT on Tuesday, September 15, 2026.

Activists also report to the SEC on MBX Biosciences, Core Scientific, Gran Tierra Energy, and Shoulder Innovations.

Investing.com -- In a note to clients on Wednesday, Citi analysts reiterated their bullish silver price targets, saying the metal could climb to $90 an ounce over the next six to 12 months as investment demand takes over from a softening industrial picture.

Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the promotion of Jon Osborne to Chief Commercial Officer, effective August 6, 2026. Mr. Osborne, who most recently served as Vice President of Commercial Development, will now have responsibility for all elements of Shoulder Innovations' commercial organization and will work closely with

Investing.com - Citadel Securities’ Scott Rubner has started advocating for adding structural exposure to gold for the first time in 2026, calling the current precious metals setup "one of the more compelling upside setups we have seen in precious metals in months."

Company raises full-year guidance to $67-$69 million amid strong market share gains and strategic partnerships

Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the second quarter ended June 30, 2026.

Investing.com -- Texas Precious Metals remains bullish on gold and silver despite recent price weakness, viewing the current pullback as an opportunity for investors to accumulate positions as strong central bank buying and growing retail demand continue to underpin the market, a company executive said.

Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will present at the Canaccord Genuity 46th Annual Growth Conference. The presentation will take place at 1:30 p.m. ET / 10:30 a.m. PT on Wednesday, August 12, 2026.

Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the second quarter of 2026 after market close on Thursday, August 6, 2026.